Donor-Specific Antibodies in the Absence of Rejection Are Not a Risk Factor for Allograft Failure
Open Access
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Kidney International Reports
- Vol. 4 (8) , 1057-1065
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Value of Donor–Specific Anti–HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft LossJournal of the American Society of Nephrology, 2016
- Current outcomes of chronic active antibody mediated rejection – A large single center retrospective review using the updated BANFF 2013 criteriaHuman Immunology, 2016
- Nature, timing, and severity of complications from ultrasound-guided percutaneous renal transplant biopsyTransplant International, 2016
- Donor-Specific Antibodies Adversely Affect Kidney Allograft OutcomesJournal of the American Society of Nephrology, 2012
- De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant GlomerulopathyTransplantation, 2012
- Clinical role of the renal transplant biopsyNature Reviews Nephrology, 2012
- Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and NonadherenceAmerican Journal of Transplantation, 2011
- Identifying Specific Causes of Kidney Allograft LossAmerican Journal of Transplantation, 2009
- Four-year Follow-up of a Prospective Trial of HLA and MICA Antibodies on Kidney Graft SurvivalAmerican Journal of Transplantation, 2007
- Biopsy of the Transplanted KidneySeminars in Interventional Radiology, 2004